Clinical trial
Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear…
NCT00328874 · German Parkinson Study Group (GPS), Other · Completed
Key facts
| NCT number | NCT00328874 |
|---|---|
| Title | Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy |
| Official title | Mono-center, Prospective, Double-blind, Placebo-controlled, Randomized Clinical Phase IIa Trial to Assess the Safety, Tolerability, and Immediate Biological Effects of Coenzyme Q10 - nanoQuinon® in Progressive Supranuclear Palsy |
| Lead sponsor | German Parkinson Study Group (GPS), Other |
| Collaborators | MSE Pharmazeutika GmbH, Louisenstr.114D-61348 Bad Homburg, Germany Pitzer Stiftung Philipps University Marburg |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Progressive Supranuclear Palsy |
| Intervention type | Drug |
| Interventions | Coenzyme Q10 |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | May 24, 2006 |
| Last update posted | Jan 10, 2020 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: